{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:01:41Z","timestamp":1750219301360,"version":"3.41.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260202"],"award-info":[{"award-number":["82260202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jcjo.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T05:47:54Z","timestamp":1730267274000},"page":"156-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of relapses with visual outcomes in optic neuritis: a post hoc analysis of the Optic Neuritis Treatment Trial"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4825-1792","authenticated-orcid":false,"given":"Ruitong","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaijung","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4879-5159","authenticated-orcid":false,"given":"Yi","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2024.10.005_bib0001","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archopht.1997.01100160715008","article-title":"Visual function 5 years after optic neuritis: experience of the Optic Neuritis Treatment Trial","volume":"115","year":"1997","journal-title":"Arch Ophthalmol (Chicago, Ill : 1960)"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108580","article-title":"Risk factors for idiopathic optic neuritis recurrence","volume":"9","author":"Du","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0003","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00417-018-04217-7","article-title":"Incidence and timing of recurrence of optic neuritis","volume":"257","author":"Park","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jfma.2012.02.001","article-title":"Clinical prospective study of visual function in patients with acute optic neuritis","volume":"112","author":"Wang","year":"2013","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0005","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/ene.13753","article-title":"Acute idiopathic optic neuritis: not always benign","volume":"25","author":"Deschamps","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171880","article-title":"Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis","volume":"12","author":"Matsumoto","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0007","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial","volume":"14","author":"Cleary","year":"1993","journal-title":"Controlled Clin Trials"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0008","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaophthalmol.2013.7995","article-title":"Association of race\/ethnicity with visual outcomes following acute optic neuritis: an analysis of the Optic Neuritis Treatment Trial","volume":"132","author":"Moss","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0009","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/1352458520937281","article-title":"Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody","volume":"27","author":"Deschamps","year":"2021","journal-title":"Multiple Scler (Houndmills, Basingstoke, England)"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0010","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s00415-017-8606-9","article-title":"Prognostic factors and disease course in aquaporin-4 antibody-positive Chinese patients with acute optic neuritis","volume":"264","author":"Kang","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0011","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajo.2022.01.015","article-title":"Vision prognosis and associated factors of optic neuritis in dependence of glial autoimmune antibodies","volume":"239","author":"Yang","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0012","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/WNO.0000000000001554","article-title":"Long-term visual prognosis in patients with aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder","volume":"42","author":"Moon","year":"2022","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0013","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ophtha.2023.05.024","article-title":"Predictors of poor visual outcome in myelin oligodendrocyte glycoprotein-related optic neuritis","volume":"130","author":"Handzic","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0014","doi-asserted-by":"crossref","first-page":"e2089","DOI":"10.1212\/WNL.0000000000006574","article-title":"Racial differences in neuromyelitis optica spectrum disorder","volume":"91","author":"Kim","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archneurol.2011.1426","volume":"69","author":"Kinkel","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jcjo.2024.10.005_bib0016","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaophthalmol.2017.6757","article-title":"Prevalence of myelin oligodendrocyte glycoprotein and aquaporin-4-igG in patients in the Optic Neuritis Treatment Trial","volume":"136","author":"Chen","year":"2018","journal-title":"JAMA Ophthalmol"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224003120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418224003120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:58:55Z","timestamp":1750132735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418224003120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0008418224003120"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.10.005","relation":{},"ISSN":["0008-4182"],"issn-type":[{"type":"print","value":"0008-4182"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of relapses with visual outcomes in optic neuritis: a post hoc analysis of the Optic Neuritis Treatment Trial","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}